Literature DB >> 2067202

Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro.

G Coritsidis1, V Rifici, S Gupta, J Rie, Z H Shan, J Neugarten, D Schlondorff.   

Abstract

Hyperlipidemia may contribute to the pathogenesis of glomerular sclerosis. We therefore compared binding and uptake of native LDL and oxidized LDL (Ox-LDL) to cultured mesangial cells (MC) and the resulting effects on prostaglandin generation and cell proliferation. Ox-LDL, prepared from native LDL by incubation with copper, was bound to MC in a concentration dependent manner with a four- to fivefold increase in binding over LDL. In competition binding experiments Ox-LDL competed to 90% with LDL for binding sites, but LDL only displaced Ox-LDL to 15%. Furthermore polyinosinic acid, which blocks binding of Ox-LDL to macrophages, inhibited binding of Ox-LDL but not that of LDL to MC. Mesangial cells also preferentially took up Ox-LDL over LDL, and Ox-LDL resulted in higher [14C] oleate incorporation into cholesteryl esters than LDL, findings consistent with different handling of Ox-LDL and LDL by MC. LDL slightly stimulated mesangial cell proliferation at low concentration (10 to 50 micrograms/ml of LDL) returning to control levels at 100 and 250 micrograms/ml. In contrast Ox-LDL inhibited cell proliferation in a concentration-dependent manner, starting at concentrations as low as 10 to 25 micrograms/ml of Ox-LDL. Direct observations of mesangial cells by phase contrast microscopy confirmed the cytotoxic effects of Ox-LDL. Addition of Ox-LDL to mesangial cells resulted in a concentration-dependent increase in PGE2 synthesis within one hour, while at this time point LDL had no significant effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2067202     DOI: 10.1038/ki.1991.108

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice.

Authors:  Monika Patel; Xiaoxin X Wang; Lilia Magomedova; Rohan John; Adil Rasheed; Hannah Santamaria; Weidong Wang; Ricky Tsai; Liru Qiu; Arturo Orellana; Andrew Advani; Moshe Levi; Carolyn L Cummins
Journal:  Diabetologia       Date:  2013-11-08       Impact factor: 10.122

2.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 3.  Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.

Authors:  Jacek Rysz; Anna Gluba-Brzózka; Maciej Banach; Andrzej Więcek
Journal:  Int Urol Nephrol       Date:  2015-03-11       Impact factor: 2.370

4.  Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

Authors:  Joel Thompson; Patricia Wilson; Katie Brandewie; Deepa Taneja; Liliana Schaefer; Bonnie Mitchell; Lisa R Tannock
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

Review 5.  Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis.

Authors:  H J Gröne; A K Walli; E F Gröne
Journal:  Clin Investig       Date:  1993-10

Review 6.  The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system.

Authors:  H H Radeke; K Resch
Journal:  Clin Investig       Date:  1992-09

Review 7.  An update on the lipid nephrotoxicity hypothesis.

Authors:  Xiong Z Ruan; Zac Varghese; John F Moorhead
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

8.  Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.

Authors:  Ali C M Johnson; Julie M Yabu; Sherry Hanson; Vallabh O Shah; Richard A Zager
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

9.  CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.

Authors:  Paul Gutwein; Mohamed Sadek Abdel-Bakky; Kai Doberstein; Anja Schramme; Janet Beckmann; Liliana Schaefer; Kerstin Amann; Anke Doller; Nicole Kämpfer-Kolb; Abdel-Aziz H Abdel-Aziz; El Sayed M El Sayed; Josef Pfeilschifter
Journal:  J Cell Mol Med       Date:  2009-05-01       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.